Reducing Hereditary Cancer Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Reducing Hereditary Cancer Act aims to improve access to healthcare for individuals with a family history of hereditary cancer. It expands Medicare coverage to include germline mutation testing for those with a personal or family history of such mutations, as well as coverage for risk-reducing surgeries and certain cancer screenings. The bill also adjusts frequency limitations for screenings based on genetic testing results and incorporates evidence-based guidelines for these services.
Key provisions
- Expands Medicare coverage for germline mutation testing for individuals with a family history of hereditary cancer.
- Provides coverage for risk-reducing surgeries based on evidence-based guidelines for individuals with inherited cancer mutations.
- Increases the frequency of evidence-based screenings (mammography, colonoscopy, PSA testing, etc.) for individuals with hereditary cancer gene mutations.
- Establishes guidelines for germline mutation testing, referencing nationally recognized oncology professional organizations.
- Defines ‘germline mutation testing’ according to evidence-based clinical practice guidelines.
- Allows for more frequent screenings for individuals with identified hereditary cancer mutations.
- Includes screening mammography, breast screening MRI, colonoscopy, PSA testing, and other appropriate screenings.
- Updates coverage rules to align with evidence-based guidelines.
Who is affected
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
33 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours